Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study
Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performa...
出版年: | Cognition, Brain, Behavior. An Interdisciplinary Journal |
---|---|
第一著者: | |
フォーマット: | 論文 |
言語: | English |
出版事項: |
ASCR Publishing House
2018
|
オンライン・アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045 |
id |
Chik M.W.; Hazalin N.A.M.N.; Singh G.K.S. |
---|---|
spelling |
Chik M.W.; Hazalin N.A.M.N.; Singh G.K.S. 2-s2.0-85048866924 Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study 2018 Cognition, Brain, Behavior. An Interdisciplinary Journal 22 1 10.24193/cbb.2018.22.02 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045 Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performance of rats when injected directly into the hippocampal region of the brain in order to mimic the pathological aspects of human Alzheimer's disease. Four months old Sprague-Dawley rats were divided into control (no treatment), two sham-operated (injected with 5 and 10 µl phosphate buffer saline respectively) and two STZ treatment groups (3 mg/kg bw; 5 µl and 6 mg/kg bw; 10 µl). STZ and vehicle were injected bilaterally as a single injection into the rats' dorsal hippocampus. After 3 months of STZ administration, the level of cognitive impairment was assessed using the Morris water maze. Both STZ-treated groups showed significant impairment on the acquisition of spatial memory (escape latency and total distance travelled) and retrieval of spatial memory (time spent in the target quadrant). However, STZ administered at 6 mg/kg bw induced severe neurotoxicity as evidenced by mortality and destruction of the brain region at the injection site with presence of large lesions. Therefore, low dose of STZ (3 mg/kg bw) administered in the intrahippocampal is sufficient to demonstrate memory impairment that can be used as a suitable rodent Alzheimer's disease model. These findings contribute in assisting researchers to decide the concentration of STZ to develop sporadic Alzheimer's disease rat model for the studies on prevention, detection and possible cure for the disease. © 2018 ASCR Publishing House. All Rights ederved. ASCR Publishing House 22479228 English Article |
author |
2-s2.0-85048866924 |
spellingShingle |
2-s2.0-85048866924 Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
author_facet |
2-s2.0-85048866924 |
author_sort |
2-s2.0-85048866924 |
title |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
title_short |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
title_full |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
title_fullStr |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
title_full_unstemmed |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
title_sort |
Chronic intrahippocampal administration of streptozotocin targeting insulin receptors induced memory loss in rats: A dose comparison study |
publishDate |
2018 |
container_title |
Cognition, Brain, Behavior. An Interdisciplinary Journal |
container_volume |
22 |
container_issue |
1 |
doi_str_mv |
10.24193/cbb.2018.22.02 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048866924&doi=10.24193%2fcbb.2018.22.02&partnerID=40&md5=5d75fbd9e3b71bb7b3226a8315134045 |
description |
Streptozotocin (STZ) induced neurotoxicity via intracerebroventricular administration is currently used as one of the accepted rodent model that represents sporadic Alzheimer's disease. The present study aimed to investigate the effects of different STZ concentrations on spatial memory performance of rats when injected directly into the hippocampal region of the brain in order to mimic the pathological aspects of human Alzheimer's disease. Four months old Sprague-Dawley rats were divided into control (no treatment), two sham-operated (injected with 5 and 10 µl phosphate buffer saline respectively) and two STZ treatment groups (3 mg/kg bw; 5 µl and 6 mg/kg bw; 10 µl). STZ and vehicle were injected bilaterally as a single injection into the rats' dorsal hippocampus. After 3 months of STZ administration, the level of cognitive impairment was assessed using the Morris water maze. Both STZ-treated groups showed significant impairment on the acquisition of spatial memory (escape latency and total distance travelled) and retrieval of spatial memory (time spent in the target quadrant). However, STZ administered at 6 mg/kg bw induced severe neurotoxicity as evidenced by mortality and destruction of the brain region at the injection site with presence of large lesions. Therefore, low dose of STZ (3 mg/kg bw) administered in the intrahippocampal is sufficient to demonstrate memory impairment that can be used as a suitable rodent Alzheimer's disease model. These findings contribute in assisting researchers to decide the concentration of STZ to develop sporadic Alzheimer's disease rat model for the studies on prevention, detection and possible cure for the disease. © 2018 ASCR Publishing House. All Rights ederved. |
publisher |
ASCR Publishing House |
issn |
22479228 |
language |
English |
format |
Article |
accesstype |
|
record_format |
scopus |
collection |
Scopus |
_version_ |
1828987878485524480 |